Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06869252 · ClinicalTrials.gov registry record · Phase 1
Autologous Adipose Cells Therapy
A Phase 1 study of Hair Thinning and Fine Lines, sponsored by CERM.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
- 2
- Study locations
NCT06869252: Recruiting Phase 1 study of Hair Thinning and Fine Lines, sponsored by CERM.
NCT06869252 is a Phase 1 study of Hair Thinning and Fine Lines that is actively recruiting participants, run by CERM. The registered enrollment target is 40 participants, below the 62-participant average among 10 other Hair Thinning trials with a reported enrollment target (35% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06869252, a Phase 1 study of Hair Thinning and Fine Lines, is actively recruiting participants, sponsored by CERM.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
- 2
- Study locations
Study Summary
Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell Therapy for skin rejuvenation and hair improvement in human application.
Primary Outcome
30 people will be randomly selected to rank the level of improvement by comparing the images captured at pro and post-treatment from Imaging assessment. Scale of Improvement: * No Improvement(0%) * Minimal Improvement(1% - 25%) * Moderate Improvement(26% - 50%) * Significant Improvement(51% - 75%) * Major Improvement(76% - 100%)
Conditions Studied
Interventions
- BIOLOGICAL Autologous Adipose Cells Therapy
Study Locations (2)
Delaware
- The Centre for Cosmetic Surgery & Medicine, Newark - Lewes
- The Centre for Cosmetic Surgery & Medicine - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2025-08-01 |
| Est. Completion | 2026-02-01 |
| Phase | Phase 1 |
What NCT06869252 shows while recruiting
NCT06869252 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 62-participant average among 10 other Hair Thinning trials with a reported enrollment target (35% lower).
The record links to 8 conditions, with Hair Thinning appearing as the primary indexed condition, and to 1 intervention - of which Autologous Adipose Cells Therapy is the first listed.
NCT06869252 reports a single indexed study location in Delaware.
Frequently Asked Questions
What is clinical trial NCT06869252 about?
NCT06869252 is a clinical study titled "Autologous Adipose Cells Therapy". Autologous Adipose Cell Therapy is a series of process designated to address the demerits of the traditional autologous fat grafting and dermal fillers, while enhancing the versatility and aesthetic outcomes. In this study, the goal is to evaluate the safety and efficacy of Autologous Adipose cell T...
What is the current status of trial NCT06869252?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2025-08-01. Estimated completion is 2026-02-01.
What conditions does trial NCT06869252 study?
This clinical trial studies the following conditions: Hair Thinning, Fine Lines, Skin Pigmentation, Skin Elasticity, Hair Loss/Baldness.
What interventions are being tested in trial NCT06869252?
The interventions under investigation include: Autologous Adipose Cells Therapy (BIOLOGICAL).
Who is sponsoring clinical trial NCT06869252?
This trial is sponsored by CERM, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06869252 being conducted?
This trial has 2 study locations across Delaware. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hair Thinning
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06869252's enrollment target sits among peer trials
40 8th of 10 higher than 2 of 10 other Hair Thinning trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hair Thinning trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Evaluating the Combined Use of Supplement and Serum in Promoting Hair Growth in Women With Self-perceived Thinning Hair
RECRUITING · NA
-
A Clinical Trial to Examine the Efficacy of a Dietary Supplement to Improve the Health and Appearance of Hair.
ACTIVE NOT RECRUITING · NA
-
A Clinical Trial to Examine the Efficacy of a Supplement to Support Healthy Hair and Skin
ACTIVE NOT RECRUITING · NA
-
Efficacy and Safety of TargetCool + Benev Exosomes in Patients With Hair Thinning
ACTIVE NOT RECRUITING · NA
-
The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome
ACTIVE NOT RECRUITING · NA
-
Efficacy and Safety of a Nutraceutical Supplement With Standardized Botanicals in Women With Thinning Hair
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI